Institutional Manager · CIK 0001958125
Catalio Capital Management, LP
NEW YORK, NY · File #028-25237
Latest AUM
$565.8M
Positions
45
Top-10 Concentration
51.2%
Filings
5
Portfolio Value Over Time
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | ABBVIE INC | 00287Y109 | -154,834 | -$35.9M | $0 |
| NEW | GILEAD SCIENCES INC | GILD | +289,312 | +$35.5M | $0 |
| NEW | BRISTOL-MYERS SQUIBB CO | CELG-RI | +647,899 | +$34.9M | $0 |
| REDUCE | ELI LILLY & CO | LLY | -31,453 | -$33.8M | +$17.9M |
| EXITED | BRIDGEBIO PHARMA INC | 10806X102 | -622,729 | -$32.3M | $0 |
| NEW | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | +410,700 | +$31.4M | $0 |
| REDUCE | STRUCTURE THERAPEUTICS INC | GPCR | -398,909 | -$27.7M | +$27.1M |
| NEW | JOHNSON & JOHNSON | JNJ | +120,840 | +$25.0M | $0 |
| REDUCE | INTUITIVE SURGICAL INC | ISRG | -44,134 | -$25.0M | +$8.5M |
| REDUCE | NATERA INC | NTRA | -86,096 | -$19.7M | +$10.1M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202545 pos · $565.8M
- 13F HOLDINGS REPORTQ/E Sep 202538 pos · $540.9M
- 13F HOLDINGS REPORTQ/E Jun 202540 pos · $476.9M
- 13F HOLDINGS REPORTQ/E Mar 202537 pos · $411.1M
- 13F HOLDINGS REPORTQ/E Dec 202433 pos · $457.1M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES INC | GILD | 289,312 | $35.5M | 6.28% |
| 2 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 647,899 | $34.9M | 6.18% |
| 3 | BOSTON SCIENTIFIC CORP | BSX | 360,428 | $34.4M | 6.07% |
| 4 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 410,700 | $31.4M | 5.55% |
| 5 | ELI LILLY & CO | LLY | 25,923 | $27.9M | 4.92% |
| 6 | DIANTHUS THERAPEUTICS INC | DNTH | 653,572 | $26.9M | 4.76% |
| 7 | ASCENDIS PHARMA A/S | ASND | 119,265 | $25.4M | 4.49% |
| 8 | SYNDAX PHARMACEUTICALS INC | SNDX | 1,196,807 | $25.1M | 4.44% |
| 9 | JOHNSON & JOHNSON | JNJ | 120,840 | $25.0M | 4.42% |
| 10 | REGENERON PHARMACEUTICALS | REGN | 29,797 | $23.0M | 4.07% |
| 11 | STRUCTURE THERAPEUTICS INC | GPCR | 252,901 | $17.6M | 3.11% |
| 12 | SOLENO THERAPEUTICS INC | SLNO | 360,340 | $16.7M | 2.95% |
| 13 | CYTOKINETICS INC | CYTK | 258,381 | $16.4M | 2.90% |
| 14 | EDWARDS LIFESCIENCES CORP | EW | 187,048 | $15.9M | 2.82% |
| 15 | INTUITIVE SURGICAL INC | ISRG | 27,209 | $15.4M | 2.72% |
| 16 | NATERA INC | NTRA | 62,273 | $14.3M | 2.52% |
| 17 | ADAPTIVE BIOTECHNOLOGIES COR | ADTI | 821,195 | $13.3M | 2.36% |
| 18 | ABIVAX SA | AAVXF | 98,514 | $13.3M | 2.35% |
| 19 | SUPERNUS PHARMACEUTICALS INC | SUPN | 257,465 | $12.8M | 2.26% |
| 20 | FRACTYL HEALTH INC | GUTS | 5,491,866 | $12.1M | 2.14% |